Genzyme 2004 Annual Report - Home About Genzyme Site Map Legal Disclaimer
Genzyme 2004 Annual Report
Genzyme Logo
Table of Contents
2004 - A Transforming Year
Financial Highlights
Letter To Shareholders
A Future of Hope
Building a Sustainable Future
Focused Medical Areas
Genetic Diseases
Renal Disease
Orthopaedics
Oncology
Comprehensive Oncology Franchise
Products and Pipeline
Cancer and Endocrinology
Transplant / Immune Diseases
Genetics / Diagnostics
A Future of Innovation
A Future of Commitment
A Future of Growth
Oncology
In 2004, Genzyme established a commercial oncology franchise to provide comprehensive cancer care from diagnostics to therapeutics to follow-up monitoring.

PhotoCampath Patient
Nametag

Steve received Campath for his B-cell chronic lymphocytic leukemia after fludarabine therapy failed. Today, two-and-a-half years later, he is pursuing his career in business development, and his energy level is high. “While there is no cure, Campath did a phenomenal job of giving me back a normal life,” Steve reports.